N-(4-Fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide

Catalog No. :
ACTHGP703
CAS No. :
1291487-08-5
Molecular Formula :
C13H11FN4O2S
Molecular Weight :
306.32

IUPAC Name:N-(4-fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide

N-(4-Fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$366.00Login to see priceInquiryInquiry
250mg97%$600.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide
IUPAC NameN-(4-fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide
MDL No.MFCD18804108
Molecular FormulaC13H11FN4O2S
Molecular Weight306.32
SMILESO=S(C1=CC=CN2C1=NN=C2C)(NC3=CC=C(F)C=C3)=O
InChI KeyMMBIMICBFFWUHL-UHFFFAOYSA-N
SynonymN-(4-Fluorophenyl)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-sulfonamide;1,2,4-Triazolo[4,3-a]pyridine-8-sulfonamide, N-(4-fluorophenyl)-3-methyl-
CAS No.1291487-08-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTHGP703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNTCH137 route compound structure diagram
    ACNTCH1372146-07-8 In Stock
  4. Then
  5. ACTHGP703 route product structure diagram
    ACTHGP7031291487-08-5
Inquiry

2. ACTHGP703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNTCH137 route compound structure diagram
    ACNTCH1372146-07-8 In Stock
  4. Then
  5. ACTHGP703 route product structure diagram
    ACTHGP7031291487-08-5
Inquiry

Comments (0)